Analyst Price Targets — PRTC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 25, 2022 5:48 pm | Edward Tenthoff | Piper Sandler | $44.00 | $30.50 | TheFly | PureTech Health price target raised to $44 from $37 at Piper Sandler |
| August 9, 2022 4:36 am | — | Leerink Partners | $70.00 | $27.52 | Benzinga | SVB Leerink Maintains Outperform on PureTech Health, Raises Price Target to $70 |
| June 15, 2022 4:19 am | — | Leerink Partners | $66.00 | $19.50 | Benzinga | SVB Leerink Maintains Outperform on PureTech Health, Lowers Price Target to $66 |
| June 14, 2022 1:37 pm | Edward Tenthoff | Piper Sandler | $37.00 | $19.50 | TheFly | PureTech Health price target lowered to $37 from $72 at Piper Sandler |
Latest News for PRTC
BOSTON--(BUSINESS WIRE)--PureTech Health: Notice of Results.
BOSTON--(BUSINESS WIRE)--PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine.
PureTech Health PLC Sponsored ADR (NASDAQ: PRTC - Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 13th, there was short interest totaling 11,335 shares, a growth of 140.8% from the February 26th total of 4,707 shares. Currently, 0.0% of the company's shares are
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo (SPT-300).
BOSTON--(BUSINESS WIRE)--PureTech to Present at the Leerink Partners Global Healthcare Conference.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PRTC.
Senate Trading
No Senate trades found for PRTC.
U.S. House Trading
No House trades found for PRTC.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.